Impact of ITPA gene polymorphism for predicting anemia and treatment outcome in HCV infected patients taking Sofosbuvir Ribavirin therapy

Table 2 Demographic characteristics of patients who achieve SVR and patients who relapsed

Variable		Sustained viral response (SVR) achieved	Relapsed	P-value
	Age	40.9 ± 10.9	46.6 ± 12.3	0.462
Gender	Male	71 (54.2%)	5 (55.6%)	0.937
Gender	Female	60 (45.8%)	4 (44.4%)	0.937
Genotype rs1127354	CC	95 (72.5%)	9 (100%)	0.06
Genotype rs1127354	CA	36 (27.5%)	0%	0.06
Genotype rs7270101	AA	126 (96.2%)	7 (77.8%)	0.01
Genotype rs7270101	AC	5 (3.8%)	2 (22.2%)	0.01

ISSN: 1471-2334